A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. - Wikidata - awgldk - TriplyDB

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.

http://www.wikidata.org/entity/Q36645890

about

Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke Multicenter Evaluation of Geometric Accuracy of MRI Protocols Used in Experimental Stroke.Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update.Natalizumab: a new therapy for acute ischemic stroke?Inflammasomes link vascular disease with neuroinflammation and brain disorders.Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation.

P2860

Q28078744-1A3E2F44-BF7C-4344-8B41-5C193598C674 Q36125407-5A47F247-464F-4C5E-AED4-BDBE3DA40E84 Q36809420-70CD2369-06AB-4A18-99CC-F4E55D7ECC9A Q37239490-0F4BA339-8818-49F7-BD26-783DBCD04726 Q38914132-A3A263AE-A357-4A7C-9989-4915276CD6CD Q38916890-D0139557-9BEE-40C9-8E0B-734EA53F7BF1 Q39179831-D0D93D75-4932-449B-8A50-FCA8BB0D9F4D Q47992720-F20A76DB-504C-4AF2-928B-4E482212CD58 Q55380020-E1951F52-0FA0-44D1-B440-EDEA4592841B

P2860

A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.

http://www.wikidata.org/entity/Q36645890

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@ast

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@en

type

label

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@ast

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@en

prefLabel

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@ast

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@en

P1433

Q36645890-E12EAB77-E677-40F0-ADA7-150203FBDF4C

P1476

Q36645890-D4B27C84-350D-4C64-A0B2-3E9402E10B55

P2093

Q36645890-08CE1AC3-0582-444F-AD51-EEA3A0E74CF6

Q36645890-36FAF8C7-6C7A-44D3-84CC-B3716B79A500

Q36645890-4D712660-2675-4604-91AA-F428AE04B085

Q36645890-8E23A326-4E53-4FD8-B461-FB5CCB6EF503

Q36645890-92EDB611-3BD1-4A2A-8AD4-859D8E7D7649

Q36645890-A246817F-9126-47A5-92AC-C84EFE5178A8

Q36645890-ADCEAED3-B99D-4500-806A-A53C561B6899

P2860

Q36645890-048403D7-B1D7-4A10-A4DF-5D5D6019DC7C

Q36645890-0FAF442F-63BB-45D5-BE23-2FF809C299A2

Q36645890-127E9934-AC92-4859-BF1C-B667962744F9

Q36645890-147F095C-A71B-4499-A646-C63675F164D9

Q36645890-34299CF6-661F-4846-9AF0-A8C875D8DF7E

Q36645890-38B4ED45-A2F5-444A-9223-73EA5EA80341

Q36645890-3D5BD163-0768-4B5E-9C9A-D0850999D1E8

Q36645890-42C91456-8EF2-4DE4-9B24-D6D4EFED9CD0

Q36645890-576F4A0A-42FF-4EAE-B929-DE861576D9A8

Q36645890-64E4B1C7-55B0-401C-A1A8-080065C21E35

P304

Q36645890-D9073DD6-8FF0-460D-B357-08E07B895B92

P31

Q36645890-E33CADC6-5FA9-4352-B652-D53F2586FD60

P356

Q36645890-78407253-9D9C-4FFB-8844-05F94C4E4C44

P433

Q36645890-E07E3526-D753-42EF-8289-FBE1BE831855

P478

Q36645890-578AFF83-51C2-44D8-AAE7-CE7B9D950F7F

P50

Q36645890-209E4EB0-98A1-4533-AC70-2070B2DF3568

Q36645890-2B2C5380-F24D-4FBE-960F-7A06B970EA01

Q36645890-5CA3607D-67BB-4D6F-AA38-725179855298

Q36645890-73827BE2-852F-4561-B1E3-E9B26B4655FC

Q36645890-B0DA0871-8625-4A14-86BA-BDB7F05DC004

Q36645890-D2DD77BB-D4EC-4085-B8CC-13D3E73BA2BF

Q36645890-DB4523C4-E2B7-4652-A494-C437C2FA708D

Q36645890-EC611FBA-02D1-465F-9FAA-DE4DF34552D3

P577

Q36645890-3D001FAC-68D5-4839-BF85-B1EC8793BC73

P5875

Q36645890-B28AC23F-B40A-4646-A484-69FC6F26BB93

P698

Q36645890-D13F3A21-0531-486F-9A7A-C5816D3FFCD0

P932

Q36645890-29DEF33E-15D4-4665-AA7F-5A4B3C8880F1

P356

0271678X15606714

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

A cross-laboratory preclinical ...... receptor antagonist in stroke.

@en

P2093

Adam Denes

http://www.w3.org/2001/XMLSchema#string

Cyrille Orset

http://www.w3.org/2001/XMLSchema#string

Jari Koistinaho

http://www.w3.org/2001/XMLSchema#string

Markus Schwaninger

http://www.w3.org/2001/XMLSchema#string

Nancy J Rothwell

http://www.w3.org/2001/XMLSchema#string

Philip M Bath

http://www.w3.org/2001/XMLSchema#string

Raymond Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Progress in using systematic reviews of animal studies to improve translational research

Meta-analysis in clinical trials

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

Update of the stroke therapy academic industry roundtable preclinical recommendations

Recommendations for clinical trial evaluation of acute stroke therapies.

Interleukin-1 and acute brain injury.

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

Comparison of treatment effects between animal experiments and clinical trials: systematic review.

Interleukin-1 and neuronal injury.

Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.

P304

596-605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0271678X15606714

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Stuart M. Allan

Samaneh Maysami

Jesus M Pradillo

Md Mahbubur Rahman

Hiramani Dhungana

P577

2015-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285746694

http://www.w3.org/2001/XMLSchema#string

P698

26661169

http://www.w3.org/2001/XMLSchema#string

P932

4776311

http://www.w3.org/2001/XMLSchema#string